Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 4682172, 6 pages
http://dx.doi.org/10.1155/2016/4682172
Research Article

MicroRNA Expression Signature in Degenerative Aortic Stenosis

Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Received 4 April 2016; Accepted 28 June 2016

Academic Editor: Dragos Cretoiu

Copyright © 2016 Jing Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Thaden, V. T. Nkomo, and M. Enriquez-Sarano, “The global burden of aortic stenosis,” Progress in Cardiovascular Diseases, vol. 56, no. 6, pp. 565–571, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Rezzoug, B. Vaes, A. Pasquet et al., “Prevalence and prognostic impact of valve area-gradient patterns in patients 80 years with moderate-to-severe aortic stenosis (from the Prospective BELFRAIL Study),” American Journal of Cardiology, vol. 116, no. 6, Article ID 21248, pp. 925–932, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Bordoni, F. Saia, C. Ciuca et al., “Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study,” Giornale Italiano di Cardiologia, vol. 14, no. 4, pp. 262–268, 2013. View at Publisher · View at Google Scholar
  4. K. Arishiro, M. Hoshiga, N. Negoro et al., “Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits,” Journal of the American College of Cardiology, vol. 49, no. 13, pp. 1482–1489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. F. C. Caira, S. R. Stock, T. G. Gleason et al., “Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. 1707–1712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Galeone, D. Paparella, S. Colucci, M. Grano, and G. Brunetti, “The role of TNF-α and TNF superfamily members in the pathogenesis of calcific aortic valvular disease,” The Scientific World Journal, vol. 2013, Article ID 875363, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Latif, P. Sarathchandra, A. H. Chester, and M. H. Yacoub, “Expression of smooth muscle cell markers and co-activators in calcified aortic valves,” European Heart Journal, vol. 36, no. 21, pp. 1335–1345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Luna-Zurita, B. Prados, J. Grego-Bessa et al., “Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation,” The Journal of Clinical Investigation, vol. 120, no. 10, pp. 3493–3507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Alexopoulos, A. Kaoukis, H. Papadaki, and V. Pyrgakis, “Pathophysiologic mechanisms of calcific aortic stenosis,” Therapeutic Advances in Cardiovascular Disease, vol. 6, no. 2, pp. 71–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Pawade, D. E. Newby, and M. R. Dweck, “Calcification in aortic stenosis: the skeleton key,” Journal of the American College of Cardiology, vol. 66, no. 5, pp. 561–577, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Lerman, S. Prasad, and N. Alotti, “Calcific aortic valve disease: molecular mechanisms and therapeutic approaches,” European Cardiology Review, vol. 10, no. 2, pp. 108–112, 2015. View at Publisher · View at Google Scholar
  12. K. E. Yutzey, L. L. Demer, S. C. Body et al., “Calcific aortic valve disease: a consensus summary from the alliance of investigators on calcific aortic valve disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 11, pp. 2387–2393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Sathyamurthy and S. Alex, “Calcific aortic valve disease: is it another face of atherosclerosis?” Indian Heart Journal, vol. 67, no. 5, pp. 503–506, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. L. A. Yates, C. J. Norbury, and R. J. C. Gilbert, “The long and short of microRNA,” Cell, vol. 153, no. 3, pp. 516–519, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Thum and G. Condorelli, “Long noncoding RNAs and microRNAs in cardiovascular pathophysiology,” Circulation Research, vol. 116, no. 4, pp. 751–762, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Liu, J. Xiao, H. Zhu et al., “miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling,” Cell Metabolism, vol. 21, no. 4, pp. 584–595, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. F. Melman, R. Shah, K. Danielson et al., “Circulating MicroRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis a translational pilot study,” Circulation, vol. 131, no. 25, pp. 2202–2216, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wang, Y. Bei, S. Shen et al., “miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2,” Journal of Molecular and Cellular Cardiology, vol. 94, pp. 43–53, 2016. View at Publisher · View at Google Scholar
  19. D. Lv, J. Liu, C. Zhao et al., “Targeting microRNAs in pathological hypertrophy and cardiac failure,” Mini-Reviews in Medicinal Chemistry, vol. 15, no. 6, pp. 475–478, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. N. M. Rajamannan, F. J. Evans, E. Aikawa et al., “Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease—2011 update,” Circulation, vol. 124, no. 16, pp. 1783–1791, 2011. View at Google Scholar
  21. B. Yanagawa, F. Lovren, Y. Pan et al., “miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis,” Journal of Thoracic and Cardiovascular Surgery, vol. 144, no. 1, pp. 256–e2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Zhang, X. Liu, X. Zhang et al., “MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells,” Journal of Thoracic and Cardiovascular Surgery, vol. 147, no. 3, pp. 1073–1080.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Ohukainen, S. Syvaranta, J. Napankangas et al., “MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease,” Annals of Medicine, vol. 47, no. 5, pp. 423–429, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Rysä, “Gene expression profiling of human calcific aortic valve disease,” Genomics Data, vol. 7, pp. 107–108, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. J. F. Esmerats, J. Heath, and H. Jo, “Shear-sensitive genes in aortic valve endothelium,” Antioxidants & Redox Signaling, 2016. View at Publisher · View at Google Scholar
  26. S. Coffey, M. J. Williams, L. V. Phillips, and G. T. Jones, “Circulating microRNA profiling needs further refinement before clinical use in patients with aortic stenosis,” Journal of the American Heart Association, vol. 4, no. 8, Article ID e002150, 2015. View at Publisher · View at Google Scholar
  27. J. Xiao, D. Liang, Y. Zhang et al., “MicroRNA expression signature in atrial fibrillation with mitral stenosis,” Physiological Genomics, vol. 43, no. 11, pp. 655–664, 2011. View at Publisher · View at Google Scholar · View at Scopus